These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4017456)

  • 1. [Evaluation of the clinical efficacy of fosfomycin lozenges in the prevention of complications in surgical interventions in odontostomatology].
    Dolci G; Amato R; Scaramella F; Vergnani M
    Clin Ter; 1985 Jan; 112(2):131-9. PubMed ID: 4017456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the clinical efficacy of fosfomycin in soluble tablets in the therapy of infectious processes of the oral cavity].
    Dolci G; Amato R; Scaramella F; Vergnani M
    Clin Ter; 1984 Aug; 110(4):345-51. PubMed ID: 6237870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phosphomycin in tablets that dissolve in the mouth: clinical evaluation in oral medicine].
    Dolci G; De Luca M
    Dent Cadmos; 1985 Nov; 53(18):101-3. PubMed ID: 3869552
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with the use of fosfomycin in dentistry].
    Longo A; Mazza E
    Dent Cadmos; 1986 Apr; 54(7):117-9. PubMed ID: 3460858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of fosfomycin in bacterial infections of the oral cavity in childhood].
    Ghezzi F; Zallio F
    Minerva Stomatol; 1985; 34(4):703-6. PubMed ID: 3862951
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 8. [The propionic ester of erythromycin. Its value in dento-oral infections].
    Benito Quintela F
    Rev Esp Estomatol; 1982; 30(4):283-90. PubMed ID: 6963709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Macroral: clinical study for evaluating efficacy and tolerance of miocamycin in infections in odontostomatology].
    Moniaci D; Bocca M; Anglesio FG; Mozzati M
    Minerva Stomatol; 1989 May; 38(5):519-22. PubMed ID: 2668717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of fosfomycin in dental infectious pathology].
    Cofini S; Agopovich G; Arcuri C
    Clin Ter; 1984 Dec; 111(6):539-43. PubMed ID: 6525813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical effects of erythrocin for the infectious diseases of the mouth].
    Suzuki S; Noshiro T; Kuga Y; Fukuda J; Hida J
    Shikai Tenbo; 1978; 52(3):533-9. PubMed ID: 295915
    [No Abstract]   [Full Text] [Related]  

  • 12. Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria.
    Dinh A; Salomon J; Bru JP; Bernard L
    Scand J Infect Dis; 2012 Mar; 44(3):182-9. PubMed ID: 22176655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fosfomycin: a further clinical contribution in oral cavity pathology].
    Gualandi G; Cornacchia N; Bondi MG
    Clin Ter; 1984 Oct; 111(1):53-6. PubMed ID: 6238780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of peroral fosfomycin in dental interventions].
    Cornacchia N; Molinari L
    Minerva Stomatol; 1986 Dec; 35(12):1205-8. PubMed ID: 3547072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phosphomycin for the prevention of bacterial infections in high risk patients].
    Faedda R; Tocco A; Vacca R; Deplano A; Olmeo NA; Branca FG; Bartoli E
    Clin Ter; 1981 Nov; 99(3):295-304. PubMed ID: 7307457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fosfomycin. II. Antimicrobial activity in vivo].
    Carlone NA; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1977; 70(7-12):215-25. PubMed ID: 615746
    [No Abstract]   [Full Text] [Related]  

  • 17. [Odontogenic maxillofacial infections. Surgical treatment].
    Curuchaga E
    Odontol Postgrado; 1989 Jul; 2(3-4):6-17. PubMed ID: 2638735
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-microbial agents used in dentistry--part III.
    Gillman MA
    J Dent Assoc S Afr; 1983 Jan; 38(1):18-9. PubMed ID: 6576498
    [No Abstract]   [Full Text] [Related]  

  • 19. [Macrolide antibiotics for oral intake in the treatment and prevention of suppurative surgical infection].
    Govorovich EA; Martshak AM; Iakovlev VP
    Antibiotiki; 1976 Apr; 21(4):371-5. PubMed ID: 1275486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antibiotics in the treatment of infectious diseases in dentistry.
    Goldberg RJ
    Pa Dent J (Harrisb); 1982; 49(5):6-7, 9. PubMed ID: 6183633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.